Brief by Shorts91 Newsdesk / 09:57am on 06 May 2024,Monday India
The Supreme Court will hear a petition regarding a rare side-effect of the Covishield COVID-19 vaccine, developed by AstraZeneca and Oxford University. The petition demands an expert panel to investigate the side-effect, thrombosis with thrombocytopenia syndrome (TTS), and compensation for families of those who may have died or become disabled after taking the vaccine. AstraZeneca has acknowledged that TTS can occur in rare cases. The petition also seeks directions for the government to provide compensation to those affected. A hearing date has not been set, but the Chief Justice has acknowledged the issue.
